NCT05497726View on ClinicalTrials.gov

Fluorescent Sentinel Lymph Node Identification in Colon Carcinoma Using Intravenous Bevacizumab-800CW

NACompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

January 27, 2023

Primary Completion Date

July 10, 2023

Study Completion Date

October 10, 2023

Conditions
Colorectal NeoplasmsColon NeoplasmSentinel Lymph NodeFluorescence
Interventions
PROCEDURE

Sentinel lymph node detection using intravenous bevacizumab-800CW

Sentinel lymph node detection using intravenous bevacizumab-800CW

Trial Locations (1)

3813TZ

Meander Medisch Centrum, Amersfoort

Sponsors
All Listed Sponsors
lead

Meander Medical Center

OTHER